Facts are, insurance ratings are really dependent on the notion that some people are higher risk than others.

No one is immune from addiction; it afflicts people of all ages, races, classes, and professions.

Opioid replacement therapy is the standard evidence-based model to treat people with acute opioid addiction, and that is unassailable according to every research study that's been done. If that is the evidence-based model, then why can't we meet the large-scale need that's out there? We can't because one, there aren't enough doctors who can prescribe [drugs like methadone], and two, there are these artificial limits [by insurers] on who doctors can prescribe to.

And how the government communicates about homeland security is central to how the public responds.

If we do not provide education for every single American, we are consigning those without an education to second-class status.

Our contention is not that medication alone is the answer. We really need to have it in conjunction with cognitive behavioral therapy and with peer support. And that needs to be reimbursed [by health insurers], because it shows huge reductions in overall spending.

In the last 5 years, American employers have lost over $150 billion of productivity to depression alone. That is more than the GDP of 28 different States during the same period.